| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 848 |
| Opened positions | 143 |
| Closed positions | 89 |
| Increased positions | 325 |
| Reduced positions | 254 |
| 13F shares | Current |
|---|---|
| Total value | 19.75 tn |
| Total shares | 89.89 mm |
| Total puts | 1.31 mm |
| Total calls | 338.55 k |
| Total put/call ratio | 3.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 18.17 mm | $4.16 tn |
| BlackRock | 12.61 mm | $2.88 tn |
| STT State Street | 6.47 mm | $1.48 tn |
| BK The Bank of New York Mellon Corporation | 5.43 mm | $1.24 tn |
| Geode Capital Management | 3.94 mm | $899.86 bn |
| MS Morgan Stanley | 3.88 mm | $886.26 bn |
| IVZ Invesco | 2.33 mm | $531.71 bn |
| NTRS Northern Trust | 1.70 mm | $389.37 bn |
| Charles Schwab Investment Management | 957.02 k | $218.86 bn |
| Ubs Global Asset Management Americas | 954.61 k | $218.31 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Feb 25 | Sandercock Brett | ResMed Common Stock | Sell | Dispose S | No | Yes | 238.98 | 1,000 | 238.98 k | 91,864 |
| 7 Feb 25 | Farrell Michael J. | ResMed Common Stock | Sell | Dispose S | No | Yes | 236.772 | 8,009 | 1.90 mm | 455,472 |
| 7 Feb 25 | Farrell Michael J. | ResMed Common Stock | Option exercise | Acquire M | No | Yes | 101.64 | 8,009 | 814.03 k | 463,481 |
| 7 Feb 25 | Farrell Michael J. | ResMed Common Stock Options ResMed Common Stock | Option exercise | Dispose M | No | No | 101.64 | 8,009 | 814.03 k | 72,083 |
| 5 Feb 25 | Farrell Peter C | ResMed Common Stock | Sell | Dispose S | No | Yes | 242.11 | 2,000 | 484.22 k | 77,218 |
| 3 Feb 25 | Michael J Rider | ResMed Common Stock | Sell | Dispose S | No | Yes | 242.42 | 64 | 15.51 k | 8,974 |
| 8 Jan 25 | Sandercock Brett | ResMed Common Stock | Sell | Dispose S | No | Yes | 234.04 | 1,000 | 234.04 k | 92,864 |
